Gyros Protein Technologies introduces a multi-species kit for pharmacokinetic studies

New kit for early-stage biotherapeutic development, optimized for use in Gyrolab™ systems

Uppsala, Sweden, 05 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new kit for early-stage biotherapeutic pharmacokinetic (PK) studies.

‍